64-X has a total of 15 patents globally. Of these 15 patents, more than 80% patents are active. Canada and Europe are where 64-X has filed the maximum number of patents, followed by United States of America. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of 64-X.
64-X was founded in the year 2017. The company creates novel methods for producing highly optimized and otherwise unachievable cell lines for the production of viral vectors, with a focus on those used for cell and gene therapies. They do this by utilizing an integrated computational design loop and a throughput discovery and screening platform.
Do read about some of the most popular patents of 64-X which have been covered by us in this article and also you can find 64-X patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over 64-X patent portfolio.
How many patents does 64-X have?
64-X has a total of 15 patents globally. These patents belong to 3 unique patent families. Out of 15 patents, 12 patents are active.
How Many Patents did 64-X File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | 64-X Applications Filed | 64-X Patents Granted |
| 2023 | 1 | – |
| 2021 | 6 | – |
| 2020 | 8 | – |
How many 64-X patents are Alive/Dead?
Worldwide Patents
How Many Patents did 64-X File in Different Countries?
Countries in which 64-X Filed Patents
| Country | Patents |
| Canada | 3 |
| Europe | 3 |
| United States Of America | 2 |
| Israel | 1 |
| Japan | 1 |
| Australia | 1 |
Where are Research Centers of 64-X Patents Located?
The Research Centre for all the 64-X patents is the United States of America.
List of 64-X Patents
| 64-X Patents | Title |
| US20220282263A1 | Engineered Organisms And Uses Thereof In The Production Of Biologics, Reagents, Diagnostics And Research Tools |
| US20220228104A1 | Engineered Organisms And Uses Thereof As Living Medicines, Research Tools, Food Products, Or Environmental Tools |
| EP4208547A1 | Mammalian Cells And Methods For Engineering The Same |
| EP3969562A1 | Engineered Organisms And Uses Thereof In The Production Of Biologics, Reagents, Diagnostics And Research Tools |
| EP3969563A1 | Engineered Organisms And Uses Thereof As Living Medicines, Research Tools, Food Products, Or Environmental Tools |
| WO2023167860A1 | Insect Cells And Methods For Engineering The Same |
| CA3191396A1 | Mammalian Cells And Methods For Engineering The Same |
| CA3136564A1 | Engineered Organisms And Uses Thereof As Living Medicines, Research Tools, Food Products, Or Environmental Tools |
| CA3136560A1 | Engineered Organisms And Uses Thereof In The Production Of Biologics, Reagents, Diagnostics And Research Tools |
| JP2023539700A | Mammalian Cells And Methods For Modifying Them |
| IL301021A | Mammalian Cells And Methods For Engineering The Same |
| AU2021338299A1 | Mammalian Cells And Methods For Engineering The Same |
| WO2022051418A1 | Mammalian Cells And Methods For Engineering The Same |
| WO2020232314A1 | Engineered Organisms And Uses Thereof As Living Medicines, Research Tools, Food Products, Or Environmental Tools |
| WO2020232312A1 | Engineered Organisms And Uses Thereof In The Production Of Biologics, Reagents, Diagnostics And Research Tools |
What are 64-X key innovation segments?
What Technologies are Covered by 64-X?
The chart below distributes patents filed by 64-X